THC
60
-5
CCI
30
-11
NAVI
52
-2
XOM
42
-6
HRB
59
2
C
62
4
PBI
56
-2
COP
57
-2
PG
50
2
WU
24
4
KO
38
-3
INTU
58
-3
MO
60
-2
REGN
38
-2
CSX
57
-4
ROP
53
-9
CNP
54
10
EXC
54
3
CMA
61
-3
VRTX
47
-6
THC
60
-5
CCI
30
-11
NAVI
52
-2
XOM
42
-6
HRB
59
2
C
62
4
PBI
56
-2
COP
57
-2
PG
50
2
WU
24
4
KO
38
-3
INTU
58
-3
MO
60
-2
REGN
38
-2
CSX
57
-4
ROP
53
-9
CNP
54
10
EXC
54
3
CMA
61
-3
VRTX
47
-6
Financhill
Back

Amplify Cash Flow Dividend Leaders ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
43

COWS
Amplify Cash Flow Dividend Leaders ETF

Last Price:
30.74
Seasonality Move:
14.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
43
Amplify Cash Flow Dividend Leaders ETF (COWS) is a Sell

Is Amplify Cash Flow Dividend Leaders ETF a Buy, Sell or Hold?

  • The current Amplify Cash Flow Dividend Leaders ETF [COWS] share price is $30.39. The Score for COWS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • COWS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

COWS Stock Price Chart

What is Amplify Cash Flow Dividend Leaders ETF's stock price today?

  • The Amplify Cash Flow Dividend Leaders ETF share price today is $30.39
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COWS is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

COWS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 56.12 Buy
Chaikin Money Flow: -1544 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.43 - 30.57) Buy
Bollinger Bands (100): (28.31 - 29.99) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

COWS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.71 Sell
20-day SMA: 29.97 Buy
50-day SMA: 29.68 Buy
200-day SMA: 28.73 Buy
8-day EMA: 30.52 Sell
20-day EMA: 30.19 Buy
50-day EMA: 29.77 Buy
200-day EMA: 28.41 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Amplify Cash Flow Dividend Leaders ETF Earnings Growth & COWS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Amplify Cash Flow Dividend Leaders ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):